The switching model of latent inhibition: an update of neural substrates
- PMID: 9401704
- DOI: 10.1016/s0166-4328(97)02314-0
The switching model of latent inhibition: an update of neural substrates
Abstract
Organisms exposed to a stimulus which has no significant consequences, show subsequently latent inhibition (LI), namely, retarded conditioning to this stimulus. LI is considered to index the capacity to ignore irrelevant stimuli and its disruption has recently received increasing interest as an animal model of cognitive deficits in schizophrenia. Initial studies indicated that LI is disrupted by systemic or intra-accumbens injections of amphetamine and hippocampal lesions, and potentiated by systemic administration of neuroleptics. On the basis of these findings, the switching model of LI proposed that LI depends on the subicular input to the nucleus accumbens (NAC). Subsequent studies supported and refined this proposition. Lesion studies show that LI is indeed disrupted by severing the subicular input to the NAC, and further implicate the entorhinal/ventral subicular portion of this pathway projecting to the shell subterritory of the NAC. There is a functional dissociation between the shell and core subterritories of the NAC, with lesions of the former but not of the latter disrupting LI. This suggests that the shell is necessary for the expression and the core for the disruption of LI. The involvement of the NAC has been also demonstrated by findings that LI is disrupted by intra-accumbens injection of amphetamine and potentiated by DA depletion or blockade in this structure. Disruption and potentiation of LI by systemic administration of amphetamine and neuroleptics, respectively, have been firmly established, and in addition, have been shown to be sensitive to parametric manipulations of the LI procedure. LI is unaffected by lesions and DA manipulations of medial prefrontal cortex and lesions of basolateral amygdala. The implications of these findings for LI as an animal model of schizophrenia are discussed.
Similar articles
-
The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment.Psychopharmacology (Berl). 2003 Sep;169(3-4):257-97. doi: 10.1007/s00213-002-1313-x. Epub 2003 Feb 25. Psychopharmacology (Berl). 2003. PMID: 12601500 Review.
-
Latent inhibition: the nucleus accumbens connection revisited.Behav Brain Res. 1997 Oct;88(1):27-34. doi: 10.1016/s0166-4328(97)02313-9. Behav Brain Res. 1997. PMID: 9401705 Review.
-
Differential involvement of the shell and core subterritories of the nucleus accumbens in latent inhibition and amphetamine-induced activity.Behav Brain Res. 1996 Nov;81(1-2):123-33. doi: 10.1016/s0166-4328(96)00051-4. Behav Brain Res. 1996. PMID: 8950008
-
Latent inhibition is disrupted by nucleus accumbens shell lesion but is abnormally persistent following entire nucleus accumbens lesion: The neural site controlling the expression and disruption of the stimulus preexposure effect.Behav Brain Res. 2005 Jul 30;162(2):246-55. doi: 10.1016/j.bbr.2005.03.019. Epub 2005 Apr 18. Behav Brain Res. 2005. PMID: 15970218
-
Basolateral amygdala lesions do not disrupt latent inhibition.Behav Brain Res. 1995 Dec 14;72(1-2):73-81. doi: 10.1016/0166-4328(96)00056-3. Behav Brain Res. 1995. PMID: 8788859
Cited by
-
Differences in serotonin and dopamine metabolism in the rat brain in latent inhibition.Neurosci Behav Physiol. 2003 Mar;33(3):217-22. doi: 10.1023/a:1022139028628. Neurosci Behav Physiol. 2003. PMID: 12762587
-
Functional networks underlying latent inhibition learning in the mouse brain.Neuroimage. 2007 Oct 15;38(1):171-83. doi: 10.1016/j.neuroimage.2007.06.031. Epub 2007 Jul 18. Neuroimage. 2007. PMID: 17703956 Free PMC article.
-
Differential role of muscarinic transmission within the entorhinal cortex and basolateral amygdala in the processing of irrelevant stimuli.Neuropsychopharmacology. 2010 Apr;35(5):1073-82. doi: 10.1038/npp.2009.210. Epub 2010 Jan 13. Neuropsychopharmacology. 2010. PMID: 20072122 Free PMC article.
-
Enhanced neurotensin neurotransmission is involved in the clinically relevant behavioral effects of antipsychotic drugs: evidence from animal models of sensorimotor gating.J Neurosci. 2001 Jan 15;21(2):601-8. doi: 10.1523/JNEUROSCI.21-02-00601.2001. J Neurosci. 2001. PMID: 11160439 Free PMC article.
-
Relationship between behavioral measures of anxiety and latent inhibition in mature rats.Learn Behav. 2019 Mar;47(1):59-65. doi: 10.3758/s13420-018-0331-4. Learn Behav. 2019. PMID: 29926398 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources